Genome Editing/Genome Engineering Market Worth 6.28 Billion USD by 2022

PUNE, India, November 20, 2017 /PRNewswire/ --

According to a new market research report "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022", published by MarketsandMarkets™, the global market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5% during the forecast period. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 96 Market Data Tables and 42 Figures spread through 164 Pages and in-depth TOC on "Genome Editing/Genome Engineering Market"

https://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html
Early buyers will receive 10% customization on this report

CRISPR to account for the largest technology segment in the genome editing/genome engineering market in 2017 

The technology segment of the Genome Editing Market is classified into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to command the largest share of the global Genome Editing Market in 2017. The large share of this segment can be attributed to the potential advantage of CRISPR is its ability to multiplex, that is, to use multiple guide RNAs in parallel to target multiple sites simultaneously in the same cell, making it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=231037000  

Cell line engineering to dominate the genome editing/genome engineering market during the forecast period 

By application, the Genome Editing Market is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is estimated to account for the largest share of the global market in 2017. Growing industry focus on stem cell research, increasing global awareness about stem cell therapies, and increasing funding from governments and private organizations are driving the growth of the cell line engineering segment.

Biotechnology & pharmaceutical companies to dominate the genome editing/genome engineering market during the forecast period 

By end user, the Genome Editing Market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The biotechnology & pharmaceutical companies segment is estimated to account for the largest share of the global Genome Editing Market in 2017. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

Talk To Our Research Analysts: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=231037000

North America to dominate the market in 2017 

North America is expected to dominate the global Genome Editing Market in 2017. Factors such as increasing use of genetically modified crops, the development of gene therapy in the US, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.

Some of the major players in the Genome Editing Market are Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).

Browse Related Reports 

Dental Digital X-Ray Market by Product (Digital, Analog), Type (Intraoral, Extraoral (CBCT, Panoramic), Hybrid X-ray), Application (Diagnostic, Therapeutics, Forensic), End User (Dental Clinics, Forensic Laboratories) - Global Forecast to 2020

https://www.marketsandmarkets.com/Market-Reports/dental-digital-x-ray-market-102002511.html

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit Our Blog: http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets